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ABSTRACT  
Neuropsychological studies of adults with problem gambling indicate impairments in many 
cognitive areas. Catechol-O-methyltransferase (COMT) plays a unique role in the regulation of 
dopamine in the prefrontal cortex and has been proposed to play a role in the cognitive 
dysfunction of problem gambling. This study examined adults with varying levels of gambling 
behavior to determine whether COMT genotype was associated with differences in gambling 
symptoms and cognitive functioning.  260 non-treatment-seeking adults aged 18-29 years with 
varying degrees of gambling behavior provided saliva samples for genotyping COMT val158met 
(rs4680). All subjects underwent clinical evaluations and neurocognitive assessment of decision-
making, working memory, and impulsivity. The Val/Val genotype was associated with the 
largest percentage of subjects with gambling disorder (31.8%), a rate significantly different from 
the Val/Met (13.2%) group (p=0.001).  The Val/Val group was also associated with significantly 
more gambling disorder diagnostic criteria, greater frequency of gambling behavior, significantly 
worse cognitive performance on the Cambridge Gamble Task (risk adjustment and delay 
aversion) and the Spatial Working Memory task (total errors). This study adds to the growing 
literature on the role of COMT in impulsive behaviors by showing that the Val/Val genotype was 
associated with specific clinical and cognitive elements among young adults who gamble, in the 
absence of differences on demographic measures and other cognitive domains. Future work 
should consider using COMT genotyping to track whether certain genotypes predict which 
young people will develop gambling disorder or other impulsive behaviors over time. 
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Introduction 
Problem gambling represents a significant public health problem characterized by 
persistent and recurrent maladaptive patterns of gambling and is associated with impaired 
functioning (Hodgins et al., 2011). Problem gambling-related impairment may impact on every 
aspect of a person’s life and many feel ill equipped to cope (Thon et al., 2014).  
Neuropsychological studies of adults with problem gambling indicate impairments in 
many cognitive areas including inhibition, working memory, decision-making, cognitive 
flexibility, and executive planning (Ledgerwood et al, 2012; Goudriaan et al, 2006). Dopamine is 
a neurotransmitter that regulates cognitive functions dependent on the fronto-striatal circuitry, 
and dopamine dysregulation has been suggested as playing a key role in a range of impulsive 
behaviors, particularly those related to inhibitory control and decision making (Malloy-Diniz et 
al., 2013).  The catechol-O-methyltransferase (COMT) enzyme plays a unique role in the 
regulation of dopamine in the prefrontal cortex (Tunbridge et al., 2004) and has been proposed to 
be a potential target for the treatment of cognitive dysfunction in a number of psychiatric 
illnesses, especially those characterized by high rates of impulsivity (Scheggia et al., 2012). A 
recent pharmacological treatment study for problem gambling found that the COMT inhibitor, 
tolcapone, improved gambling behavior and that this improvement was associated with enhanced 
fronto-parietal brain activation during planning (Grant et al., 2013).  
In the frontal lobes, COMT is the enzyme largely responsible for the inactivation of 
synaptic dopamine (Tunbridge et al., 2004).  A common functional polymorphism in the COMT 
gene, the Val substitution at codon 158 [rs4680 (val158met)], results in a ~40% increase in 
enzymatic activity and thereby reduces cortical dopamine levels (Lotta et al., 1995). Carriers of 
the Val allele exhibit less efficient prefrontal neural signaling and relative deficits in executive 
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cognitive functioning (Diaz-Asper et al., 2008; Dumontheil et al., 2010). Therefore, individuals 
homozygous for the Val allele are expected to have decreased levels of dopamine in comparison 
to individuals with two met alleles and should exhibit greater problems with executive 
functioning and impulsivity.  
Studies of healthy control subjects, however, have demonstrated mixed results with 
respect to COMT genotype, cognitive performance, trait impulsivity, and impulsive behaviors. In 
an early study, the Met allele was predictive of enhanced performance on the Wisconsin Card 
Sorting test, and more efficient physiological responses in the prefrontal cortices (Egan et al., 
2001). Another study found that Met subjects outperformed Val subjects on an N-Back working 
memory task (Farrell et al., 2012), while the same research group also found that the COMT 
polymorphism affected functional connectivity of the brain in the resting state (Tunbridge et al., 
2013).  One study found no differences between COMT genotype groups on a battery of 19 
cognitive tasks including cognitive flexibility, memory, and visual processing (Dennis et al., 
2010). A later study, however, found that health controls homozygous for the met allele 
demonstrated better performance on a cognitive task of executive functioning (Trail-Making 
Test) (Wishart et al., 2011). Other studies have shown that healthy control subjects homozygous 
for the Met allelic variant exhibited better performance on tasks of working memory and the 
Wisconsin Card Sorting Task compared to subjects homozygous for Val (Malhotra et al., 2002; 
Rosa et al., 2004). Conversely, van Den Bos and colleagues (2009) found that healthy control 
female subjects who were Met/Met homozygous chose more disadvantageously on the Iowa 
Gambling Task than subjects homozygous for valine (Val/Val). Similarly, a study of 82 healthy 
volunteers found that those with a Met/Met genotype had higher impulsivity scores on the 
Barratt Impulsiveness Scale compared to either Val/Met or Val/Val subjects (Soeiro-De-Souza et 
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al., 2013).  Clinically, a study of 139 healthy controls found that COMT met/met homozygotes 
were more likely to be at-risk gamblers and mild problem drinkers compared to Val/Val 
homozygotes (Guillot et al., 2014). To further complicate the picture, a small genome-wide 
association study from the national community-based Australian Twin Registry did not find an 
association between COMT rs4680 and disordered gambling in 1312 twins (Lind et al. 2013). 
One potential explanation for discordant results in relation to cognition and the COMT 
polymorphism is that different optimal levels of dopamine are required for different cognitive 
functions; there may be a ‘trade off’ with higher dopamine (as seen with the Met variant) being 
associated with relatively superior improvement in some domains, with relative impairments in 
others. This suggestion would fit with an inverted ‘U’ model of executive functioning (e.g. 
Robbins & Arnsten, 2009; Kehagia et al., 2013). 
Unlike previous studies examining COMT genotyping in healthy controls and seeking to 
explain impulsive behaviors, this study sought to examine COMT genotypes in a large sample of 
individuals with varying levels of gambling behavior to determine whether COMT genotype was 
associated with differences in gambling phenomenology and cognitive functioning. We 
hypothesized that those Val/Val homozygote gamblers, compared to Met carriers, would exhibit 
greater problem gambling severity, relative impairment in spatial working memory, relative 
impairment in decision-making, and no differences with respect to response inhibition (since the 
latter appears to be under noradrenergic control) (Bari and Robbins, 2013).   
 
Material and Methods 
Subjects 
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Participants comprised non-treatment-seeking young adults aged 18-29 years, recruited as 
part of an ongoing longitudinal study of impulsive behaviors. Subjects who had gambled at least 
five times during the preceding 12 months (i.e. a proxy for some baseline level of gambling 
behavior and impulsivity) responded to media announcements in two large metropolitan areas, 
and were compensated with a $50 gift card to a local department store for their participation. 
Inability to understand/undertake the procedures and to provide voluntary, written informed 
consent were exclusionary criteria. Since we sought to examine a naturalistic sample of people 
reflective of the broader population, subjects with psychiatric and substance use comorbidity, as 
well as those subjects currently taking psychotropic medications, were all allowed to participate.  
The study procedures were carried out in accordance with the most recent version of the 
Declaration of Helsinki. The Institutional Review Board of the University of Chicago approved 
the study and the informed consent procedures. After all study procedures were explained and 
subjects had the opportunity to ask questions, subjects provided voluntary written informed 
consent.   
  
Assessments 
Raters assessed each subject using the Structured Clinical Interview for Gambling 
Disorder (SCI-GD), a nine-item instrument assessing symptoms of Gambling Disorder: a score 
of 0 reflected ‘low risk’, a score of 1-3 was consistent with ‘at risk’ gambling, and a score of ≥4 
fulfilled the diagnostic criteria for gambling disorder. The SCI-GD is a modification of the 
DSM-IV based Structured Clinical Interview for Pathological Gambling (SCI-PG) (Grant et al., 
2004) but omits the illegal acts criterion as it is no longer included in the DSM-5.  
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In addition, subjects were asked about frequency of gambling behavior, money lost 
gambling, and they completed the Yale-Brown Obsessive-Compulsive Scale Modified for 
Pathological Gambling (PG-YBOCS), which is a clinician-administered instrument that assesses 
thoughts, urges and gambling behavior over the seven days preceding assessment (Pallanti et al., 
2005). 
Subjects undertook a detailed interview incorporating clinical and cognitive evaluations. 
Occurrence of psychiatric conditions was evaluated using the Mini International 
Neuropsychiatric Inventory (MINI) (Sheehan et al., 1998), and the Minnesota Impulsive 
Disorders Interview (MIDI) (Grant, 2008). The former examines mainstream psychiatric 
conditions (e.g., depression), while the latter is tailored to detect impulse control disorders, 
namely binge-eating disorder, kleptomania, trichotillomania, intermittent explosive disorder, 
pyromania, compulsive buying, and compulsive sexual behavior.  
Participants undertook the following cognitive paradigms at baseline, using a touch-
screen computer in conjunction with the Cambridge Neuropsychological Test Automated Battery 
(CANTABeclipse, version 3, Cambridge Cognition Ltd, Cambridge, UK). Task order was fixed 
(indicated by order of task descriptions below). Cognitive testing took up to 50 minutes to 
complete and was done in one continuous session. The cognitive domains of interest were 
selected because they have been particularly strongly implicated in the pathophysiology of 
gambling problems, and we focused on spatial working memory, decision-making, and response 
inhibition (Clark, 2010; Van Holst et al., 2010).  
Aspects of decision-making were examined using the Cambridge Gamble Task (CGT) 
(Lawrence et al., 2009). There were four practice trials followed by eight blocks of nine trials. At 
the start of each block, the ‘cumulative points’ was reset to 100. On each trial, subjects were 
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presented with a set of red and blue boxes, totaling ten. The ratio of red:blue boxes were varied 
over the course of the task pseudo-randomly (box-ratios: 9_1, 8_2, 7_3, 6_4). Subjects were 
informed that for each trial, the computer had hidden a ‘token’ inside one of the boxes, and that 
they had to decide whether they felt the token would be hidden behind a red or a blue box. After 
selecting ‘red’ or ‘blue’ using the touch-screen interface, subjects were required to gamble a 
proportion of their points as to whether this choice was correct or incorrect. The key outcome 
measures were: delay aversion (tendency towards wanting to make speedy responses rather than 
wait); quality of decision-making (i.e., the proportion of trials where the volunteer chose red 
when red boxes were in the majority and vice versa – i.e., made the logical color choice); the 
mean proportion of points gambled at each box-ratio; and risk adjustment (i.e., tendency to 
adjust how much one is betting depending on the degree of risk).  
We assessed response inhibition using the Stop Signal Task, a paradigm in which the 
subject viewed a series of directional arrows appearing one per time on-screen, and made 
speeded motor responses depending on the direction of each arrow (Aron et al., 2004). On a 
subset of trials, an auditory stop-signal occurred (‘beep’) to indicate to volunteers that response 
suppression was needed for the given trial. This task estimated the time taken by each 
volunteer’s brain to suppress an already triggered command.  
Subjects underwent the Spatial Working Memory tasks (SWM) to examine aspects of 
strategy and working memory (Owen et al., 1990). Subjects attempt to locate tokens hidden 
underneath boxes on-screen and try to avoid returning to boxes that previously yielded such 
tokens. The key outcome measures include the “total number of errors” (inappropriately 
returning to boxes that previously yielded tokens), and “strategy score” (lower score equates to 
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superior strategy use), for each level of task difficulty. The spatial working memory paradigm is 
dependent on distributed circuitry including the prefrontal cortices (Owen et al., 1990). 
 
COMT Status 
 Saliva was taken for analysis of COMT val158met (rs4680 G to A) genotyping. COMT 
val158met (rs4680) was the only gene examined in this study.  TaqMan probes and primers were 
designed and synthesized by Applied Biosystems Inc. DNA samples were genotyped using 
TaqMan SNP Genotyping Assays (Applied Biosystems Inc., Foster City, CA) using standard 
reagents and standard cycling protocols. Data were managed by The Applied Biosystems’ ABI 
7900 Real-Time Basic Software. Researchers involved in genotyping were blind to 
neuropsychological results, and researchers involved in neuropsychological assessments were 
blind to the genotyping results. COMT genotype was coded as a categorical variable (met/met, 
met/val and val/val) for further analysis. 
 
Data Analysis 
Subjects were compared based COMT status. Salient demographic, clinical, and 
cognitive variables were tabulated for the three groups. Differences between the groups were 
explored using independent sample t-tests (majority of measures that were single in nature) or 
chi-square tests (for binary variables). Where significant group differences were found, effect 
sizes were reported (Cohen's D). Statistical significance was defined as p<0.05, two-tailed, 
uncorrected. IBM SPSS Software, Version 21 was used for the analyses. 
 
Results 
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The COMT genotype distribution was under Hardy-Weinberg equilibrium (χ2=3.47, 
p=0.55). The distribution of COMT genotype in our subjects were n=61 met/met, n=114 
Val/Met, and n=85 Val/Val. The percentage of each level of gambling severity within each 
genotype group is presented in Figure 1. The Val/Val group had the most subjects with gambling 
disorder (31.8%), a rate significantly different from the Val/Met (13.2%) group (p=0.001). The 
Val/Val group was also associated with significantly more gambling disorder diagnostic criteria 
(reflected by the total number of SCI-GD criteria met) and greater frequency of gambling 
behavior compared to the met/met group (Table 1). In addition, comparison of the Val/Val group 
with the Val/Met group showed that they had significantly worse gambling symptoms (reflected 
by the subscales and total score of the PG-YBOCS) and met more SCI-GD criteria.  
Table 2 shows the differences between COMT groups for the cognitive tasks. Although 
no differences were found on the stop signal task, the Val/Val group exhibited significantly 
worse cognitive performance on the CGT (risk adjustment and delay aversion) as well as on the 
SWM (total errors). 
 
Discussion 
This is the first study to explore clinical and cognitive associations between gambling 
behavior and COMT genotype in a large sample of young adults who gamble to varying degrees. 
Unlike many prior studies, we examined COMT genotypes in a representative non-treatment 
seeking community sample enriched for gambling behaviors. In this group of young adult 
gamblers, we found that a higher rate (31.8%) of the Val/Val group met criteria for gambling 
disorder compared to rates of 13.2% and 19.7% in the Val/Met and Met/Met groups, 
respectively. This finding was further reflected by the greater number of diagnostic criteria met 
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by the val/val subjects as well as greater weekly frequency of gambling behavior. The finding of 
worse gambling symptomatology in the Val/Val subjects appears to be consistent with what one 
would expect in gamblers based on the mechanism of the COMT enzyme. Continued gambling 
behavior may be related to less efficient prefrontal neural signaling and problems with executive 
cognitive functioning (van Holst et al., 2010; Ledgerwood et al., 2012). Our findings, however, 
conflict with a recent study of healthy controls which found that the met/met homozygotes were 
more likely to be at-risk gamblers Val/Val homozygotes (Guillot et al., 2014). The Guillot study, 
however, enrolled subjects based on alcohol use (and excluded heavier drinkers) and screened 
for gambling as a secondary aspect of the research. Our study specifically focused on gambling 
pathology and did not exclude subjects based on any issue other than ability to consent. The 
inconsistent findings, however, raise issues regarding how lower levels of gambling pathology 
are best measured and whether a range of impulsive behaviors (and which ones) may be 
associated with COMT genotype.   
The key cognitive findings in this study were that the val/val genotype was associated 
with impaired risk adjustment and delay aversion on the Cambridge Gamble Task, and with 
spatial working memory problems, all with medium-large effect size, but intact performance on 
the task of response inhibition. The finding of decision making dysfunction in the val/val group 
was consistent with our hypothesis, but the fact that the differences were reflected by select 
measures (risk adjustment and delay aversion) rather than across all aspects of decision-making 
requires further examination. The val/val group exhibited significantly less risk adjustment than 
the met/met subjects on the task, indicating that, over the course of the task, they were 
insufficiently sensitive to changes in statistical risk and did not appropriately adjust the amount 
of points they gambled, depending on this changing risk. Gamblers tend to persist in their 
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behavior despite rising losses and this cognitive impairment in the val/val group may explain, in 
part, their difficulties with gambling.  
The val/val group also exhibited greater problems in SWM than the met/met group, in 
terms of the number of errors made. These data are consistent with those found in mice using a 
spontaneous alternation task as well as data from human studies which have shown better 
performance by Met carriers compared with Val carriers on certain tasks of working memory 
(Barnett et al, 2007; Diaz-Asper et al, 2008).  Working memory influences self-regulation as 
those with low working memory capacity show more automatic behavior than individuals with 
high working memory capacity. Deficits in working memory may result in impaired self-
regulation and by extension worse gambling behavior. 
Both of these cognitive deficits may suggest that cognitive therapy and pharmacotherapy 
for gambling behavior may ultimately wish to consider genotyping as a means of better targeting 
treatment approaches. If core cognitive deficits are shown consistently in certain subgroups of 
gamblers based on genotype, then a simple saliva test may be a useful means of directing 
patients to more successful treatment. Similarly, because tolcapone has demonstrated evidence of 
reversing certain cognitive deficits such as working memory in subjects with the val/val 
genotype (Giakoumaki et al, 2008; Farrell et al, 2012) this might be a particularly attractive 
medication option for gamblers with a combination of genotype and cognitive dysfunction 
(Grant et al., 2013).  Future research may need to consider the relationship between genotyping 
and cognitive assessment when targeting pharmacotherapies for gambling problems. 
Despite this being one of the first studies to explore the clinical and neurocognitive 
correlates of COMT genotype in young adult gamblers, several limitations should be noted. We 
selected cognitive tests based on a review of the existing literature (30) coupled with the need not 
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to expose subjects to excessively long testing batteries; as such we did not quantify all domains 
of cognition and future work could examine other functions such as temporal discounting, Iowa 
Gambling Task performance, or executive planning.  We did not track medication use in the 
subjects, and so these findings may benefit from replication in subjects who are known not to be 
taking medications. We did not exclude substance dependent individuals as we wished this to be 
an ecologically representative sample; however, our results showed that in any event the groups 
did not differ significantly on this measure. The issue of potential racial/ethnic differences in 
genotype and how this relates to gambling is clinically important, but our study was not powered 
or designed to address this issue, which merits attention in its own right in a future study.  
In summary, this study adds to the growing literature on the role of COMT in impulsive 
behaviors by showing that the val/val genotype was associated with specific clinical and 
cognitive elements among young adults who gamble, in the absence of differences on 
demographic measures and other cognitive domains. Future work should consider using COMT 
genotyping to track whether certain genotypes predict which young people will develop 
gambling disorder or other impulsive behaviors over time.
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 Table 1. Demographic and Clinical Characteristics of Gamblers based on COMT Status  
 
  
 p-values Effect Size 
Met/Met 
 (N=61) 
Val/Met 
(N=114) 
Val/Val 
(N=85) 
Val/Val 
Vs. 
Val/Met 
Met/Met 
Vs. 
Val/Met 
Val/Val 
Vs. 
Met/Met 
Val/Val 
Vs. 
Val/Met 
Met/Met 
Vs. 
Val/Met 
Val/Val 
Vs. 
Met/Met 
Age, years 26.1 (10.7) 23.8 (6.9) 27.0 (10.2) .011t .088t .638t .367 - - 
Sex 
female, n (%) 20 (32.8) 42 (36.8) 39 (45.9) .199c .593c .112c - - - 
Ethnicity 
Caucasian, n (%) 41 (75.9) 75 (69.4) 42 (57.5) .153c .444c .097c - - - 
Education, n (%) 
 Some college + 55 (90.2) 
103 
(90.4) 77 (90.6) .955c .968c .932c - - - 
Gambling Level, n (%) 
   Disordered 
   At-Risk 
   Low-Risk 
 
12 (19.7) 
17 (27.9) 
32 (52.5) 
 
15 (13.2) 
33 (28.9) 
66 (57.9) 
 
27 (31.8) 
28 (32.9) 
30 (35.3) 
 
.001c 
.546c 
.002c 
 
.256c 
.880c 
.490c 
 
.103c 
.513c 
.039c 
 
.226 
- 
-.224 
 
- 
- 
- 
 
- 
- 
-.171 
SCI-GD Criteria 1.5 (2.1) 1.3 (2.0) 2.3 (2.5) .001t .447t .044t .442 - .347 
PG-YBOCS, urges 3.1 (3.8) 2.5 (3.0) 4.0 (4.8) .009t .327t .201t .375 - - 
PG-YBOCS, behaviors 3.3 (4.5) 2.9 (3.5) 4.0 (4.5) .047t .452t .380t .273 - - 
PG-YBOCS, total score 6.4 (8.1) 5.4 (6.2) 8.0 (9.0) .017t .374t .266t .336 - - 
Frequency of gambling 
behavior, per week 1.5 (2.1) 
 
1.8 (2.2) 
 
 
2.4 (2.2) 
 
.158t .423t .044t - - .418 
Data refer to mean (standard deviation) unless otherwise specified.  
SCI-GD=Structured Clinical Interview for Gambling Disorder; 
PG-YBOCS=Yale-Brown Obsessive Compulsive Scale for Pathological Gambling; c=Chi Squared; t=t-test 
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Table 2. Current Comorbid Psychiatric Disorders in Gamblers based on COMT Status  
 
  
 p-values Effect Size 
Met/Met 
 (N=61) 
Val/Met 
(N=114) 
Val/Val 
(N=85) 
Val/Val 
Vs. 
Val/Met 
Met/Met 
Vs. 
Val/Met 
Val/Val 
Vs. 
Met/Met 
Val/Val 
Vs. 
Val/Met 
Met/Met 
Vs. 
Val/Met 
Val/Val 
Vs. 
Met/Met 
Major depressive 
disorder          
Bipolar disorder          
Obsessive compulsive 
disorder          
Generalized anxiety 
disorder          
Panic disorder          
Any phobia          
Post- traumatic stress 
disorder          
Alcohol use disorder          
Substance use disorder          
Any eating disorder          
Any psychotic disorder          
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Table 3. Cognitive Measures in Gamblers based on COMT Status 
  
 
Means p-values Effect Size 
Met/Met 
 (N=61) 
Val/Met 
(N=114) 
Val/Val 
(N=85) 
Val/Val 
Vs. 
Val/Met 
Met/Met 
Vs. 
Val/Met 
Val/Val 
Vs. 
Met/Met 
Val/Val 
Vs. 
Val/Met 
Met/Met 
Vs. 
Val/Met 
Val/Val 
Vs. 
Met/Met 
SST SSRT 177.21 
(63.44) 
 
181.17 
(67.53) 
 
186.46 
(63.24) 
 
.578 .709 .390 - - - 
SST median go 
reaction time 
497.02 
(180.12) 
 
485.81 
(183.17) 
 
494.41 
(165.93) 
 
.736 .700 .929 - - - 
CGT Delay aversion .24 (.25) 
 
.31 (.28) 
 
.33 (.25) 
 .502 .123 .034 - - .360 
CGT Overall 
proportion bet 
.53 (.13) 
 
.54 (.14) 
 
.55 (.13) 
 .608 .682 .405 - - - 
CGT Quality of 
decision making .95 (.09) .95 (.08) .95 (.08) .784 .879 .940 - - - 
CGT Risk adjustment 1.88 
(1.25) 
1.47 
(1.22) 
1.28 
(1.20) .284 .052 .007 - - -.490 
SWM Strategy 29.11 
(6.49) 
30.43 
(6.18) 
30.89 
(6.19) .625 .211 .119 - - - 
SWM Total Errors 15.72 
(15.81) 
19.13 
(17.14) 
22.67 
(21.37) .220 .224 .046 - - .370 
 
All values are mean (± SD)  
SST=Stop Signal Task; SSRT=Stop Signal Reaction Time; CGT=Cambridge Gamble Task; SWM=Spatial Working Memory task 
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